The Global Pulmonary Drugs Market is driven by increasing prevalence of respiratory diseases
The global pulmonary drugs market comprises drugs used for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and acute respiratory distress syndrome. Some common pulmonary drugs include bronchodilators, anti-inflammatory drugs, monoclonal antibodies, anti-infective agents, and others. These drugs...
0 Comments 0 Shares 496 Views 0 Reviews
Sponsored